The Study Of Fluconazole For Vulvovaginal Candidiasis

Status Completed

Clinical Trial Summary

As for the indication of vulvovaginal candidiasis, a single oral administration of fluconazole 150 mg has been approved and is recommended by guidelines overseas. However in Japan oral therapy with antifungal triazole such as Fluconazole has not been approved, and topical therapies such as vaginal tablets, pessary and cream are used clinically. The purpose of this trial is to confirm the efficacy and safety of single oral administration of fluconazole 150 mg for the treatment of vulvovaginal candidiasis in Japanese patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01806623
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	March 5, 2013
Completion date	November 22, 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05012852` - Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis	N/A
Completed	`NCT02150655` - Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women	Phase 0
Completed	`NCT00755053` - Comparative Efficacy of Ovule vs Tablet	Phase 3
Completed	`NCT02679456` - Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis	Phase 2
Completed	`NCT02242695` - Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis	Phase 4
Recruiting	`NCT06397248` - DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy
Completed	`NCT00895453` - Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC)	N/A
Completed	`NCT05327192` - VVC Sampling Study for Analysis Validation
Completed	`NCT05399641` - Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis	Phase 3
Recruiting	`NCT05079711` - Comparative Performance of a Vaginal Yeast Test
Completed	`NCT05507333` - Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis	N/A
Completed	`NCT01144286` - Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment	Phase 2
Completed	`NCT00353561` - Diabetes Mellitus and Vulvovaginal Candidiasis	Phase 3
Recruiting	`NCT05895162` - Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.	N/A
Not yet recruiting	`NCT06450990` - Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection	Phase 1/Phase 2
Recruiting	`NCT05908682` - Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Completed	`NCT02203942` - Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis	N/A
Completed	`NCT01926028` - Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis	Phase 1/Phase 2
Completed	`NCT00194324` - Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina	Phase 4
Completed	`NCT02866227` - TOL-463 Phase 2 Study for Vaginitis	Phase 2